Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$137.50
Net Income/Share$44.18
Operating CF/Share$48.94
Free CF/Share$40.09
Cash/Share$81.49
Book Value/Share$298.76
Tangible Book/Share$285.44
Equity/Share$298.76
Interest Debt/Share$26.52
CapEx/Share$8.85
Dividend/Share$3.52
Valuation
Market Cap$82.27B
Enterprise Value$82.47B
P/E Ratio18.03
P/S Ratio5.77
P/OCF Ratio16.28
P/FCF Ratio19.80
P/B Ratio2.67
P/TB Ratio2.67
EV/Sales5.79
EV/EBITDA14.44
Graham Valuation
Graham Number$544.97
Graham Net-Net$49.46
Profitability
Earnings Yield5.55%
FCF Yield5.05%
ROE15.31%
ROIC9.18%
Return on Tangible Assets11.80%
Dividend
Dividend Yield0.44%
Payout Ratio6.06%
Capital Allocation
CapEx/OCF18.08%
CapEx/Revenue6.43%
CapEx/Depreciation1.75
SBC/Revenue7.36%
SG&A/Revenue0.00%
R&D/Revenue40.40%
Liquidity & Solvency
Debt/Equity0.09
Debt/Assets0.07
Debt/Market Cap0.03
Net Debt/EBITDA0.03
Current Ratio4.06
Interest Coverage87.61x
Income Quality1.11
Efficiency
Days Sales Outstanding146 days
Days Payables Outstanding158 days
Days Inventory571 days
Receivables Turnover2.51x
Payables Turnover2.30x
Inventory Turnover0.64x
Capital Structure
Tangible Assets$29.58B
Working Capital$13.56B
Invested Capital$19.94B
Intangibles/Assets3.44%